Generic Drug Approvals Still Winning The Pandemic At US FDA
Approvals Peak In June As Complete Responses Fall To A Low
Executive Summary
Productivity remains high as full ANDA approvals reached a FY 2020 peak and complete responses dropped to another low in June.